This program will discuss important postmenopausal osteoporosis clinical and access considerations for you and your patients at high risk for fracture during the COVID-19 pandemic. Two experts in their respective fields will discuss the current situation with existing and new options to help you provide continuity of care for your patients during this time.

Featured Speakers:

John P. Bilezikian, MD, PhD, Silberberg Professor of Medicine and Pharmacology, Department of Medicine, Division of Endocrinology, Columbia University, New York, NY

Stephen M. Maylie, FRS, Syneos Health, Northeast Region

To register, click here. This program starts at 4:00PM Eastern Time.